BVS
Bioventus Inc.
NASDAQ · Healthcare · Medical - Devices · US
$10.95
−16.77%Nov 2, 2026, 21:05 UTC
Bioventus Inc. reported financial results for the three and nine months ended September 26, 2026.
Source:Aug 5, 2026, 11:30 UTC
Bioventus Inc. reported its financial results for the second quarter and first half of fiscal 2026, covering the three and six months ended June 27, 2026.
Aug 5, 2026, 00:00 UTC
Bioventus Inc. prepaid $20.0 million of its term loan principal.